Results 141 to 150 of about 169 (166)

MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH

Cell Metabolism, 2022
Gautm Bandyopadhyay, Wei Ying, Jerrold Olefsky   +2 more
exaly  

Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia

Cell Metabolism, 2022
Gregory Steinberg, Pedrum Mohammadi-Shemirani   +1 more
exaly  

NASH v. NASH

Victorian Reports, 1919
openaire   +1 more source

Vitamin B12 and folate decrease inflammation and fibrosis in NASH by preventing syntaxin 17 homocysteinylation

Journal of Hepatology, 2022
Boon Bee George Goh, Manvendra K Singh, Jin Zhou   +2 more
exaly  

Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway

Phytomedicine, 2022
Qian-Qian Xu
exaly  

Neuregulin 4 suppresses NASH-HCC development by restraining tumor-prone liver microenvironment

Cell Metabolism, 2022
Xuelian Xiong
exaly  

Efficacy of primary liver organoid culture from different stages of non-alcoholic steatohepatitis (NASH) mouse model

Biomaterials, 2020
Tsutomu Omatsu, Mohamed Elbadawy, Hideyuki Yamawaki   +2 more
exaly  

On Nash–Stackelberg–Nash games under decision-dependent uncertainties: Model and equilibrium

Automatica, 2022
Qiuwei Wu, Yunfan Zhang, Zhaojian Wang   +2 more
exaly  

The Role of Cholesterol in the Pathogenesis of NASH

Trends in Endocrinology and Metabolism, 2016
George Ioannou
exaly  

Obesity, insulin resistance, NASH and hepatocellular carcinoma

Seminars in Cancer Biology, 2013
Yu Jun, Xiang Zhang, Jiayun Shen
exaly